Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
How Does Your PICCOMPARE? A Pilot Randomized Controlled Trial Comparing Various PICC Materials in Pediatrics
Tricia Kleidon1,2, Amanda J Ullman2,3, Li Zhang2
1Children's Health Queensland, Lady Cilento Children's Hospital, South Brisbane, Queensland, Australia. tricia.kleidon@health.qld.gov.au.
Insights
The BioFlo® peripherally inserted central catheter (PICC) showed fewer complications in a pediatric feasibility trial. This innovative PICC design may offer a safer alternative to traditional PICCs, reducing thrombosis and occlusion risks.
Area of Science:
- Pediatric medical devices
- Vascular access technologies
- Clinical trial methodology
Background:
- Peripherally inserted central catheters (PICCs) are popular but associated with complications.
- Innovative materials and designs aim to reduce PICC-related thrombosis and infection.
- A large randomized trial is needed to assess these advancements.
Purpose of the Study:
- To evaluate the feasibility of a large randomized controlled trial.
- To assess PICC materials and design in reducing pediatric PICC complications.
- To compare standard polyurethane PICCs with BioFlo® PICCs.
Main Methods:
- A randomized controlled feasibility trial conducted in pediatric patients.
- 150 participants were assigned to either standard polyurethane PICCs or BioFlo® PICCs.
- Primary outcomes included trial feasibility and PICC failure rates (thrombosis, occlusion, infection, breakage, dislodgement).
Main Results:
- Protocol feasibility was confirmed with high patient and staff acceptability and zero attrition.
- PICC failure rates were lower in the BioFlo® group (11% vs. 22%).
- BioFlo® PICCs showed significantly fewer complications during use (15% vs. 34%).
Conclusions:
- BioFlo® PICCs demonstrated potential safety benefits for pediatric patients compared to standard PICCs.
- Further research is needed to confirm clinical effectiveness and cost-effectiveness.
- Investigating methods to prevent PICC failure and enhance reliability is crucial.
Background:
Despite the popularity of peripherally inserted central catheters (PICCs), recent literature highlights their potential injurious complications. Innovative PICC materials have been developed to prevent thrombosis and infection formation (Endexo®) and antireflux valves to prevent occlusion (pressure-activated safety valve®). No large randomized controlled trial has assessed these technologies. Our primary aim was to evaluate the feasibility of a large randomized controlled efficacy trial of PICC materials and design to reduce PICC complication in pediatrics.
Methods:
A randomized controlled feasibility trial was undertaken at the Lady Cilento Children's Hospital in South Brisbane, Australia, between March 2016 and November 2016. Consecutive recruitment of 150 pediatric participants were randomly assigned to receive either (1) polyurethane PICC with a clamp or (2) BioFlo® PICC (AngioDynamics Inc, Queensbury, NY). Primary outcomes were trial feasibility, including PICC failure (thrombosis, occlusion, infection, breakage, or dislodgement). Secondary outcomes were PICC complications during use.
Results:
Protocol feasibility was established, including staff and patient acceptability, timely recruitment, no missing primary outcome data, and 0% attrition. PICC failure was 22% (16 of 74, standard care) and 11% (8 of 72, BioFlo®) corresponding to 12.6 and 7.3 failures per 1000 hours (risk ratio 0.58; 95% confidence interval, 0.21-1.43; P = .172). PICC failures were primarily due to thrombosis (standard care 7% versus BioFlo® 3%) and complete occlusion (standard care 7% versus BioFlo® 1%). No blood stream infections occurred. Significantly fewer patients with BioFlo® had PICC complications during use (15% vs 34%; P = .009).
Conclusions:
BioFlo® PICCs appear potentially safer for pediatrics than traditional standard care PICCs with a clamp. Further research is required to definitively identify clinical, cost-effective methods to prevent PICC failure and improve reliability.
More Related Videos
Related Concept Videos
Pilot and Numeric Relaying
Trial and Error and Algorithm
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Random Error
Random Variables
Uppercase letters such as X or Y denote a random variable. Lowercase letters like x or y denote the value of a random variable. If X is a random variable, then X is written in words, and x is given as a number.
For example, let X = the...

